Results 61 to 70 of about 1,222,172 (308)

The View from the Top: How Strategic Human Resource Management Affects the Performance of Initial Public Offering Firms [PDF]

, 1997
We study SHRM by taking an organizational level perspective on control over all employees. Drawing from agency theory, control theory, and the resource-based view of the firm, we develop hypotheses regarding the differential effects on firm performance ...
Cyr, Linda A., Welbourne , Theresa M.
core   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

Analisis Reaksi Pasar Modal Setelah Pengumuman Initial Public Offering (Ipo) Pada Perusahaan Yang Terdaftar Di Bursa Efek Jakarta [PDF]

, 2010
Stock exchange is a means to acquire capital and accumulate funds, therefore it is important in improving the public's participation in generating fund so as to support the national development.
Idrus, M. S. (M), S, S. -. (Saint), Thoyib, A. (Armanu)   +2 more
core  

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

Molecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié, Umberto Malapelle, Catherine Alix‐Panabières, Claus Lindbjerg Andersen, Sandra Chlebowski, Vivien Lake, Caroline Lacoux, Virginie Lespinet‐Fabre, Olivier Bordone, Simon Heeke, Christophe Bontoux, Ellen Heitzer, Klaus Pantel, Paul Hofman   +13 more
wiley   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Going public and initial public offering: An exploratory study of motives from Serbian companies [PDF]

Industrija, 2012
The paper explores motives for and against going public, from the insider point of view. We employed tailor-made structured questionnaire framework to analyze advantages and disadvantages as perceived by CEO/controlling owners.
Marinković Srđan, Ljumović Isidora, Stojković Dragan   +2 more
doaj   +2 more sources

Determinan Profitabilitas Perusahaan yang Melakukan Initial Public Offering

Jurnal Riset dan Aplikasi: Akuntansi dan Manajemen, 2018
This study aims to examine whether earnings management and operating performance affect the profitability in publicly traded companies that conducted IPO policies in 2008 and whether there were differences in operating performance and the level of ...
Dwi Sulistiani, Finta Widya Oktora Maha
doaj  

Přístupy k vymezení pojmu „Initial Public Offering“ a návrh jeho českého ekvivalentu [PDF]

, 2008
V článku jsou představeny výsledky komparativní analýzy zahraničních definicí pojmu „Initial Public Offering“ a vymezeny odlišnosti od soudobého přístupu k tomuto pojmu v české literatuře.
Meluzín, Tomáš
core  

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Initial Public Offering and Corporate Governance in China's Transitional Economy [PDF]

This paper empirically investigates the performance of Chinese initial public offerings (IPOs). The data used covers the period from mid-1995 to mid-1999 with the sample including 884 companies (both in the A- and B-share markets).
Chen-Chien Hsun, Shih Hui-Tzu
core